UMROQVI Trademark
UMROQVI is a USPTO trademark filed by Sanofi Pasteur. Status: Registered.
Prosecution Summary
Trademark Summary
The standard character mark UMROQVI covers pharmaceuticals in International Class 005, including pharmaceutical preparations for use in immunology, antibodies for medical use, and preparations for the prevention and treatment of respiratory and inflammatory diseases and disorders, as well as vaccines for human use; it spans domestic classes 005, 006, 018, 044, 046, 051, and 052, with only class 005 active. The mark is registered on the Principal Register as of April 22, 2025, under registration number 7766590. Owner is Sanofi Pasteur, a French société anonyme à conseil d'administration based in Lyon, France.
Recent Activity
Filed on June 25, 2024 with priority claimed from a French application (June 24, 2024), the application faced
Trademark Facts
| Mark | UMROQVI |
|---|---|
| Serial Number | 98617625 |
| Registration Number | 7766590 |
| Status | Registered |
| Filing Date | 2024-06-25 |
| Registration Date | 2025-04-22 |
| Mark Type | Word |
| Nice Classes | 005 (Pharmaceuticals) |
| Owner | Sanofi Pasteur |
| Attorney of Record | Karen Lim |
| Prosecution Events | 18 |
| Latest Event | R.PR on 2025-04-22 |
Goods & Services
Pharmaceuticals, namely, pharmaceutical preparations for use in immunology, antibodies for medical use; pharmaceutical preparations for the prevention and treatment of respiratory and inflammatory diseases and disorders, vaccines for human use.